Masticationpedia

Difference between revisions of "Is dopaminergic medication dose associated with self-reported bruxism in Parkinson's disease? A cross-sectional, questionnaire-based study"

Is dopaminergic medication dose associated with self-reported bruxism in Parkinson's disease? A cross-sectional, questionnaire-based study (view source)

Revision as of 18:55, 27 February 2023

13,267 bytes removed ,  2 years ago
no edit summary
Line 177: Line 177:
This article has been cited by other articles in PMC.
This article has been cited by other articles in PMC.


References
{{Bib}}
 
Conflict of interest
 
interest.
 
no. 2015.461; approval date November 26th, 2015).
 
Informed consent Written informed consent was obtained from all par- ticipants in this study.
 
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adap- tation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, pro- vide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <nowiki>http://creativecommons.org/licenses/by/4.0/</nowiki>.
 
References
 
1. Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996): 896–912. <nowiki>https://doi.org/10.1016/S0140-6736(14)61393-3</nowiki>
 
2. Eimers M, Bloem B, Munneke M, Sterkenburg P, Tilburg van C (2019) ParkinsonNet in Cijfers
 
3. ParkinsonNet in Cijfers. <nowiki>https://www.parkinsonnet.nl/app/uploads/</nowiki> 2019/12/ParkinsonNet-in-cijfers-paramedische-zorg-2010-2018. pdf. Accessed on March 12, 2020
 
4. Salat D, Tolosa E (2013) Levodopa in the treatment of Parkinson’s disease: current status and new developments. J Parkinsons Dis 3(3):255–269. <nowiki>https://doi.org/10.3233/JPD-130186</nowiki>
 
5. Lobbezoo F, Ahlberg J, Raphael KG, Wetselaar P, Glaros AG, Kato T, Santiago V, Winocur E, de Laat A, de Leeuw R, Koyano K, Lavigne GJ, Svensson P, Manfredini D (2018) International consensus on the assessment of bruxism: report of a work in prog- ress. J Oral Rehabil 45(11):837–844. <nowiki>https://doi.org/10.1111/joor</nowiki>. 12663
 
6. Wetselaar P, Vermaire EJH, Lobbezoo F, Schuller AA (2019) The prevalence of awake bruxism and sleep bruxism in the Dutch adult population. J Oral Rehabil 46(7):617–623. <nowiki>https://doi.org/10.1111/</nowiki> joor.12787
 
7. Lobbezoo F, Naeije M (2001) Bruxism is mainly regulated central- ly, not peripherally. J Oral Rehabil 28(12):1085–1091. <nowiki>https://doi</nowiki>. org/10.1046/j.1365-2842.2001.00839.x
 
8. Lobbezoo F, Jacobs R, Laat de A, Aarab G, Wetselaar P, Manfredini D (2017) Chewing on bruxism: associations, conse- quences and management. Ned Tijdschr Tandheelkd 124(7-8): 369–376. <nowiki>https://doi.org/10.5177/ntvt.2017.07/08.16195</nowiki>
 
9. Lobbezoo F, Soucy JP, Montplaisir JY, Lavigne GJ (1996) Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography. J Dent Res 75(10):1804–1810. <nowiki>https://doi.org/10</nowiki>. 1177/00220345960750101401
 
10. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY (1997) The effect of the catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial. Mov Disord 12(1):73–78. <nowiki>https://doi.org/</nowiki> 10.1002/mds.870120113
 
11. de Baat C, Verhoeff MC, Ahlberg J, Manfredini D, Winocur E, Zweers P, Rozema F, Vissink A, Lobbezoo F (2020) Medications and addictive substances potentially inducing or attenuating sleep bruxism and/or awake bruxism. J Oral Rehabil 00:1–12. <nowiki>https://doi</nowiki>. org/10.1111/joor.13061
 
12. Winocur E, Gavish A, Voikovitch M, Emodi-Perlman A, Eli I (2003) Drugs and bruxism: a critical review. J Orofac Pain 17(2): 99–111
 
13. Lobbezoo F, Soucy JP, Hartman NG, Montplaisir JY, Lavigne GJ (1997) Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials. J Dent Res 76(9):1610–1614
 
14. Harris M, Nora L, Tanner CM (1987) Neuroleptic malignant syn- drome responsive to carbidopa/levodopa: support for a dopaminer- gic pathogenesis. Clin Neuropharmacol 10(2):186–189. <nowiki>https://doi</nowiki>. org/10.1097/00002826-198704000-00010
 
15. Magee KR (1970) Bruxism related to levodopa therapy. J Am Med Assoc 214(1):147. <nowiki>https://doi.org/10.1001/jama.1970</nowiki>. 03180010087026
 
16. Lavigne GJ, Soucy JP, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY (2001) Double-blind, crossover, placebo- controlled trial of bromocriptine in patients with sleep bruxism. Clin Neuropharmacol 24(3):145–149. <nowiki>https://doi.org/10.1097/</nowiki> 00002826-200105000-00005
 
17. Cahlin BJ, Hedner J, Dahlström L (2017) A randomised, open- label, crossover study of the dopamine agonist, pramipexole, in patients with sleep bruxism. J Sleep Res 26(1):64–72. <nowiki>https://doi</nowiki>. org/10.1111/jsr.12440
 
18. Verhoeff MC, Lobbezoo F, Wetselaar P, Aarab G, Koutris M (2018) Parkinson’s disease, temporomandibular disorders and bruxism: a pilot study. J Oral Rehabil 45(11):854–863. <nowiki>https://doi</nowiki>. org/10.1111/joor.12697
 
19. Markiewicz MR, Ohrbach R, McCall WD (2006) Oral Behaviors Checklist: reliability of performance in targeted waking-state be- haviors. J Orofac Pain 20(4):306–316
 
20. Schiffman E, Ohrbach R, Truelove E et al (2014) Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and re- search applications: recommendations of the International RDC/ TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache 28(1):6–27. <nowiki>https://doi.org/</nowiki> 10.11607/jop.1151
 
21. Wetselaar P, Lobbezoo F (2016) The tooth wear evaluation system: a modular clinical guideline for the diagnosis and management planning of worn dentitions. J Oral Rehabil 43(1):69–80. https:// doi.org/10.1111/joor.12340
 
22. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25(15):2649–2653. <nowiki>https://doi</nowiki>. org/10.1002/mds.23429
 
23. Olde Dubbelink KTE, Stoffers D, Deijen JB, Twisk JWR, Stam CJ, Berendse HW (2013) Cognitive decline in Parkinson’s disease is associated with slowing of resting-state brain activity: a longitudi- nal study. Neurobiol Aging 34(2):408–418. <nowiki>https://doi.org/10</nowiki>. 1016/j.neurobiolaging.2012.02.029
 
24. Lodder P (2013) To impute or not impute: that’s the question. Methodological Advice 1-7
 
25. Chen H, Cohen P, Chen S (2010) How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological stud- ies. Commun Stat Simul Comput 39(4):860–864. <nowiki>https://doi.org/</nowiki> 10.1080/03610911003650383
 
26. Kwak YT, Han IW, Lee PH, Yoon JK, Suk SH (2009) Associated conditions and clinical significance of awake bruxism. Geriatr Gerontol Int 9(4):382–390. <nowiki>https://doi.org/10.1111/j.1447-0594</nowiki>. 2009.00538.x
 
27. Khoo TK, Yarnall AJ, Duncan GW, Coleman S, O'Brien JT, Brooks DJ, Barker RA, Burn DJ (2013) The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 80(3):276–281. <nowiki>https://doi.org/10.1212/WNL.0b013e31827deb74</nowiki>
 
28. Van Selms MKA, Visscher CM, Naeije M, Lobbezoo F (2013) Bruxism and associated factors among Dutch adolescents. Community Dent Oral Epidemiol 41(4):353–363. <nowiki>https://doi.org/</nowiki> 10.1111/cdoe.12017
 
29. Ahlberg J, Rantala M, Savolainen A, Suvinen T, Nissinen M, Sarna S, Lindholm H, Kononen M (2002) Reported bruxism and stress experience. Community Dent Oral Epidemiol 30(6):405–408. <nowiki>https://doi.org/10.1034/j.1600-0528.2002.00007.x</nowiki>
 
30. Ahlberg J, Lobbezoo F, Ahlberg K, Manfredini D, Hublin C, Sinisalo J, Kononen M, Savolainen A (2013) Self-reported bruxism mirrors anxiety and stress in adults. Med Oral Patol Oral Cir Bucal 18(1):e7–e11. <nowiki>https://doi.org/10.4317/medoral.18232</nowiki>
 
31. Winocur E, Uziel N, Lisha T, Goldsmith C, Eli I (2011) Self- reported bruxism associations with perceived stress, motivation for control, dental anxiety and gagging. J Oral Rehabil 38(1):3– 11. <nowiki>https://doi.org/10.1111/j.1365-2842.2010.02118.x</nowiki>
 
32. Maria B, Sophia S, Michalis M, Charalampos L, Andreas P, John ME, Nikolaos SM (2003) Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 97(10):1151–1157. <nowiki>https://doi.org/10.1016/S0954-6111(03)00188-4</nowiki>
 
33. Ahlberg K, Savolainen A, Paju S et al (2008) Bruxism and sleep efficiency measured at home with wireless devices. J Oral Rehabil 35(8):567–571. <nowiki>https://doi.org/10.1111/j.1365-2842.2008.01875.x</nowiki>
 
34. Zorginstituut Nederland. Farmacotherapeutisch Kompas. Ziekte van Parkinson. <nowiki>https://www.farmacotherapeutischkompas.nl/</nowiki> bladeren/indicatieteksten/ziekte_van_parkinson. Accessed March 20, 2020
 
35. Østergaard K, Sunde NA (2006) Evolution of Parkinson’s disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 21(5):624–631. <nowiki>https://doi.org/10.1002/mds</nowiki>. 20776
 
36. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, van Blercom N (2005) Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 128(10):2240–2249. <nowiki>https://doi.org/10.1093/</nowiki> brain/awh571
 
37. Krack P, Batir A, Van Blercom N et al (2003) Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 349(20):1925–1934. https:// doi.org/10.1056/NEJMoa035275
 
38. Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE (2003) Long-term follow up of bilateral deep brain stim- ulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 99(3):489–495. <nowiki>https://doi.org/10</nowiki>. 3171/jns.2003.99.3.0489
 
39. Zhai S, Shen W, Graves SM, Surmeier DJ (2019) Dopaminergic modulation of striatal function and Parkinson’s disease. J Neural Transm (Vienna) 126(4):411–422. <nowiki>https://doi.org/10.1007/s00702-</nowiki> 019-01997-y
 
40. Jiménez-Silva A, Peña-Durán C, Tobar-Reyes J, Frugone-Zambra R (2017) Sleep and awake bruxism in adults and its relationship with temporomandibular disorders: a systematic review from 2003 to 2014. Acta Odontol Scand 75(1):36–58. <nowiki>https://doi.org/10.1080/</nowiki> 00016357.2016.1247465
 
41. Muzalev K, Lobbezoo F, Janal MN, Raphael KG (2017) Interepisode sleep bruxism intervals and myofascial face pain. Sleep 40(8). <nowiki>https://doi.org/10.1093/sleep/zsx078</nowiki>
 
42. Tai Y-C, Lin C-H (2020) An overview of pain in Parkinson’s dis- ease. Clin Park Relat Disord 2:1–8
 
43. Domenici RA, Campos ACP, Maciel ST, Berzuino MB, Hernandes MS, Fonoff ET, Pagano RL (2019) Parkinson’s disease and pain: modulation of nociceptive circuitry in a rat model of nigrostriatal lesion. Exp Neurol 315:72–81. <nowiki>https://doi.org/10.1016/j.expneurol</nowiki>. 2019.02.007
 
44. Manfredini D, Lobbezoo F (2009) Role of psychosocial factors in the etiology of bruxism. J Orofac Pain 23(2):153–166. <nowiki>https://doi</nowiki>. org/10.1016/j.prdoa.2019.11.004
 
45. Van’t Spijker A, Rodriguez JM, Kreulen CM, Bronkhorst EM, Bartlett DW, Creugers NHJ (2009) Prevalence of tooth wear in adults. Int J Prosthodont 22(1):35–42
 
46. Wetselaar P, Vermaire JH, Visscher CM, Lobbezoo F, Schuller AA (2016) The prevalence of tooth wear in the Dutch adult population. Caries Res 50(6):543–550. <nowiki>https://doi.org/10.1159/000447020</nowiki>
 
47. Wetselaar P, Manfredini D, Ahlberg J, Johansson A, Aarab G, Papagianni CE, Reyes Sevilla M, Koutris M, Lobbezoo F (2019) Associations between tooth wear and dental sleep disorders: a nar- rative overview. J Oral Rehabil 46(8):765–775. <nowiki>https://doi.org/10</nowiki>. 1111/joor.12807
 
48. McLean G, Hindle JV, Guthrie B, Mercer SW (2017) Co-morbidity and polypharmacy in Parkinson’s disease: insights from a large Scottish primary care database. BMC Neurol 17(1):126. https:// doi.org/10.1186/s12883-017-0904-4
 
49. Park H, Lee JY, Shin CM, Kim JM, Kim TJ, Kim JW (2015) Characterization of gastrointestinal disorders in patients with par- kinsonian syndromes. Parkinsonism Relat Disord 21(5):455–460. <nowiki>https://doi.org/10.1016/j.parkreldis.2015.02.005</nowiki>
 
50. Lobbezoo F, Ahlberg J, Glaros AG, Kato T, Koyano K, Lavigne GJ, de Leeuw R, Manfredini D, Svensson P, Winocur E (2013) Bruxism defined and graded: an international consensus. J Oral Rehabil 40(1):2–4. <nowiki>https://doi.org/10.1111/joor.12011</nowiki>
 
51. Manfredini D, Ahlberg J, Aarab G, Bracci A, Durham J, Ettlin D, Gallo LM, Koutris M, Wetselaar P, Svensson P, Lobbezoo F (2020) Towards a standardized tool for the assessment of bruxism (STAB) – overview and general remarks of a multidimensional bruxism evaluation system. J Oral Rehabil 47(5):549–556. <nowiki>https://doi.org/</nowiki> 10.1111/joor.12938


Publisher’s note Springer Nature remains neutral with regard to jurisdic- tional claims in published maps and institutional affiliations.
Publisher’s note Springer Nature remains neutral with regard to jurisdic- tional claims in published maps and institutional affiliations.
Gianni
Editor, Editors, USER, admin, Bureaucrats, Check users, dev, editor, founder, Interface administrators, member, oversight, Suppressors, Administrators, translator
11,492

edits

Retrieved from "https://www.masticationpedia.org/index.php/Special:MobileDiff/14844"